Organon has a portfolio of contraceptive and fertility brands anchored by market exclusivity for ImplanonNxt (etonogestrel implant) that has long-term growth potential.from Moneycontrol Business News https://ift.tt/3peiZIx
Thursday, June 3, 2021
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment